Upgrades
According to Stifel, the prior rating for Clearside Biomedical Inc CLSD was changed from Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. The current stock performance of Clearside Biomedical shows a 52-week-high of $2.95 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.28.
For Clearside Biomedical Inc CLSD, Needham upgraded the previous rating of Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $0.08 from the year-ago quarter. The current stock performance of Clearside Biomedical shows a 52-week-high of $2.95 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.28.
According to Gordon Haskett, the prior rating for TJX Companies Inc TJX was changed from Hold to Buy. For the second quarter, TJX Companies had an EPS of $0.69, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $77.35 and a 52-week-low of $53.69. At the end of the last trading period, TJX Companies closed at $70.08.
DZ Bank upgraded the previous rating for Take-Two Interactive Software Inc TTWO from Hold to Buy. Take-Two Interactive earned $1.30 in the second quarter, compared to $1.63 in the year-ago quarter. The stock has a 52-week-high of $182.25 and a 52-week-low of $90.00. At the end of the last trading period, Take-Two Interactive closed at $94.09.
For Purple Innovation Inc PRPL, Craig-Hallum upgraded the previous rating of Hold to Buy. In the third quarter, Purple Innovation showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. The current stock performance of Purple Innovation shows a 52-week-high of $13.84 and a 52-week-low of $2.65. Moreover, at the end of the last trading period, the closing price was at $3.41.
According to RBC Capital, the prior rating for Scienjoy Holding Corp SJ was changed from Sector Perform to Outperform. In the second quarter, Scienjoy Holding showed an EPS of $0.24, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.30 and a 52-week-low of $1.25. Scienjoy Holding closed at $1.59 at the end of the last trading period.
According to Raymond James, the prior rating for Activision Blizzard Inc ATVI was changed from Market Perform to Outperform. Activision Blizzard earned $0.68 in the third quarter, compared to $0.72 in the year-ago quarter. The stock has a 52-week-high of $86.90 and a 52-week-low of $61.99. At the end of the last trading period, Activision Blizzard closed at $71.66.
According to Loop Capital, the prior rating for Palo Alto Networks Inc PANW was changed from Hold to Buy. For the fourth quarter, Palo Alto Networks had an EPS of $0.80, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $213.63 and a 52-week-low of $140.07. Palo Alto Networks closed at $151.57 at the end of the last trading period.
Piper Sandler upgraded the previous rating for KORU Medical Systems Inc KRMD from Neutral to Overweight. For the third quarter, KORU Medical Systems had an EPS of $0.03, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $3.54 and a 52-week-low of $1.82. At the end of the last trading period, KORU Medical Systems closed at $2.31.
According to Raymond James, the prior rating for AeroVironment Inc AVAV was changed from Market Perform to Outperform. AeroVironment earned $0.10 in the first quarter, compared to $0.17 in the year-ago quarter. The current stock performance of AeroVironment shows a 52-week-high of $114.11 and a 52-week-low of $52.03. Moreover, at the end of the last trading period, the closing price was at $81.52.
According to Goldman Sachs, the prior rating for Bentley Systems Inc BSY was changed from Neutral to Buy. In the third quarter, Bentley Systems showed an EPS of $0.19, compared to $0.17 from the year-ago quarter. The current stock performance of Bentley Systems shows a 52-week-high of $48.91 and a 52-week-low of $26.32. Moreover, at the end of the last trading period, the closing price was at $34.43.
According to UBS, the prior rating for Viatris Inc VTRS was changed from Sell to Neutral. Viatris earned $0.87 in the third quarter, compared to $0.99 in the year-ago quarter. The stock has a 52-week-high of $15.60 and a 52-week-low of $8.42. At the end of the last trading period, Viatris closed at $10.83.
According to Credit Suisse, the prior rating for SunPower Corp SPWR was changed from Underperform to Neutral. For the third quarter, SunPower had an EPS of $0.13, compared to year-ago quarter EPS of $0.06. The current stock performance of SunPower shows a 52-week-high of $28.42 and a 52-week-low of $12.78. Moreover, at the end of the last trading period, the closing price was at $19.15.
See all analyst ratings upgrades.
Downgrades
Alliance Global Partners downgraded the previous rating for Agrify Corp AGFY from Buy to Neutral. Agrify earned $12.26 in the third quarter, compared to $4.70 in the year-ago quarter. The stock has a 52-week-high of $115.00 and a 52-week-low of $0.86. At the end of the last trading period, Agrify closed at $0.88.
William Blair downgraded the previous rating for Primerica Inc PRI from Outperform to Market Perform. For the third quarter, Primerica had an EPS of $3.02, compared to year-ago quarter EPS of $2.98. The current stock performance of Primerica shows a 52-week-high of $159.47 and a 52-week-low of $110.22. Moreover, at the end of the last trading period, the closing price was at $138.71.
Needham downgraded the previous rating for Rockley Photonics Holdings Ltd RKLY from Buy to Hold. In the third quarter, Rockley Photonics Hldgs showed an EPS of $0.14, compared to $0.48 from the year-ago quarter. The current stock performance of Rockley Photonics Hldgs shows a 52-week-high of $5.14 and a 52-week-low of $0.37. Moreover, at the end of the last trading period, the closing price was at $0.37.
Morgan Stanley downgraded the previous rating for QuantumScape Corp QS from Equal-Weight to Underweight. QuantumScape earned $0.27 in the third quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.68 and a 52-week-low of $6.73. QuantumScape closed at $6.74 at the end of the last trading period.
Mizuho downgraded the previous rating for AvalonBay Communities Inc AVB from Buy to Neutral. AvalonBay Communities earned $2.50 in the third quarter, compared to $2.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $259.05 and a 52-week-low of $158.35. AvalonBay Communities closed at $158.98 at the end of the last trading period.
According to HC Wainwright & Co., the prior rating for Minerva Neurosciences Inc NERV was changed from Buy to Neutral. In the third quarter, Minerva Neurosciences showed an EPS of $1.29, compared to $1.72 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.27 and a 52-week-low of $0.33. Minerva Neurosciences closed at $3.26 at the end of the last trading period.
For TechTarget Inc TTGT, Deutsche Bank downgraded the previous rating of Buy to Hold. For the third quarter, TechTarget had an EPS of $0.68, compared to year-ago quarter EPS of $0.60. The current stock performance of TechTarget shows a 52-week-high of $97.85 and a 52-week-low of $50.39. Moreover, at the end of the last trading period, the closing price was at $50.69.
B of A Securities downgraded the previous rating for Upstart Holdings Inc UPST from Neutral to Underperform. Upstart Hldgs earned $0.24 in the third quarter, compared to $0.60 in the year-ago quarter. The stock has a 52-week-high of $161.00 and a 52-week-low of $14.02. At the end of the last trading period, Upstart Hldgs closed at $17.06.
For Rigetti Computing Inc RGTI, Benchmark downgraded the previous rating of Buy to Hold. In the second quarter, Rigetti Computing showed an EPS of $0.09, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.37 and a 52-week-low of $0.98. Rigetti Computing closed at $1.11 at the end of the last trading period.
According to Benchmark, the prior rating for ATI Physical Therapy Inc ATIP was changed from Buy to Hold. ATI Physical Therapy earned $0.08 in the third quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.93 and a 52-week-low of $0.58. ATI Physical Therapy closed at $0.66 at the end of the last trading period.
For Arcturus Therapeutics Holdings Inc ARCT, Baird downgraded the previous rating of Neutral to Underperform. Arcturus Therapeutics earned $1.33 in the third quarter, compared to $2.05 in the year-ago quarter. The current stock performance of Arcturus Therapeutics shows a 52-week-high of $40.00 and a 52-week-low of $11.70. Moreover, at the end of the last trading period, the closing price was at $21.09.
For Vacasa Inc VCSA, JP Morgan downgraded the previous rating of Overweight to Neutral. The stock has a 52-week-high of $9.38 and a 52-week-low of $2.38. At the end of the last trading period, Vacasa closed at $3.58.
JP Morgan downgraded the previous rating for Amyris Inc AMRS from Neutral to Underweight. In the third quarter, Amyris showed an EPS of $0.44, compared to $0.27 from the year-ago quarter. The current stock performance of Amyris shows a 52-week-high of $6.37 and a 52-week-low of $1.44. Moreover, at the end of the last trading period, the closing price was at $1.51.
JP Morgan downgraded the previous rating for Elevation Oncology Inc ELEV from Neutral to Underweight. In the third quarter, Elevation Oncology showed an EPS of $1.67, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $6.87 and a 52-week-low of $0.90. At the end of the last trading period, Elevation Oncology closed at $0.90.
For Rigetti Computing Inc RGTI, Deutsche Bank downgraded the previous rating of Buy to Hold. In the second quarter, Rigetti Computing showed an EPS of $0.09, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $11.37 and a 52-week-low of $0.98. At the end of the last trading period, Rigetti Computing closed at $1.11.
For Edgio Inc EGIO, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. For the third quarter, Edgio had an EPS of $0.08, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $3.88 and a 52-week-low of $1.95. At the end of the last trading period, Edgio closed at $2.16.
For PARTS iD Inc ID, Canaccord Genuity downgraded the previous rating of Buy to Hold. For the third quarter, PARTS iD had an EPS of $0.18, compared to year-ago quarter EPS of $0.10. The current stock performance of PARTS iD shows a 52-week-high of $2.50 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $1.54.
For Cano Health Inc CANO, Raymond James downgraded the previous rating of Outperform to Market Perform. Cano Health earned $0.23 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Cano Health shows a 52-week-high of $9.75 and a 52-week-low of $3.30. Moreover, at the end of the last trading period, the closing price was at $3.34.
UBS downgraded the previous rating for Altria Group Inc MO from Neutral to Sell. Altria Group earned $1.28 in the third quarter, compared to $1.22 in the year-ago quarter. The stock has a 52-week-high of $57.05 and a 52-week-low of $40.35. At the end of the last trading period, Altria Group closed at $45.21.
Wolfe Research downgraded the previous rating for General Motors Co GM from Outperform to Peer Perform. General Motors earned $2.25 in the third quarter, compared to $1.52 in the year-ago quarter. The stock has a 52-week-high of $67.21 and a 52-week-low of $30.33. At the end of the last trading period, General Motors closed at $38.06.
For Vericel Corp VCEL, BTIG downgraded the previous rating of Buy to Neutral. For the third quarter, Vericel had an EPS of $0.14, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $43.97 and a 52-week-low of $17.30. At the end of the last trading period, Vericel closed at $17.65.
According to Credit Suisse, the prior rating for Hanesbrands Inc HBI was changed from Outperform to Neutral. For the third quarter, Hanesbrands had an EPS of $0.29, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $17.55 and a 52-week-low of $6.40. At the end of the last trading period, Hanesbrands closed at $6.48.
JP Morgan downgraded the previous rating for Clovis Oncology Inc CLVS from Neutral to Underweight. For the third quarter, Clovis Oncology had an EPS of $0.39, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $3.25 and a 52-week-low of $0.23. At the end of the last trading period, Clovis Oncology closed at $0.28.
According to Jefferies, the prior rating for IVERIC bio Inc ISEE was changed from Buy to Hold. IVERIC bio earned $0.35 in the third quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.33 and a 52-week-low of $8.85. IVERIC bio closed at $19.51 at the end of the last trading period.
According to Jefferies, the prior rating for Apellis Pharmaceuticals Inc APLS was changed from Buy to Hold. Apellis Pharmaceuticals earned $1.75 in the third quarter, compared to $1.57 in the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $70.00 and a 52-week-low of $33.32. Moreover, at the end of the last trading period, the closing price was at $43.99.
Oppenheimer downgraded the previous rating for Shift Technologies Inc SFT from Outperform to Perform. Shift Technologies earned $0.92 in the third quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $3.85 and a 52-week-low of $0.33. At the end of the last trading period, Shift Technologies closed at $0.35.
According to JP Morgan, the prior rating for Roblox Corp RBLX was changed from Overweight to Neutral. Roblox earned $0.50 in the third quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Roblox shows a 52-week-high of $103.79 and a 52-week-low of $21.65. Moreover, at the end of the last trading period, the closing price was at $30.92.
For CytomX Therapeutics Inc CTMX, JP Morgan downgraded the previous rating of Overweight to Underweight. For the third quarter, CytomX Therapeutics had an EPS of $0.35, compared to year-ago quarter EPS of $0.35. The current stock performance of CytomX Therapeutics shows a 52-week-high of $4.73 and a 52-week-low of $1.17. Moreover, at the end of the last trading period, the closing price was at $1.24.
Needham downgraded the previous rating for Telos Corp TLS from Buy to Hold. Telos earned $0.10 in the third quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of $16.15 and a 52-week-low of $3.35. At the end of the last trading period, Telos closed at $3.44.
See all analyst ratings downgrades.
Initiations
Morgan Stanley initiated coverage on ProKidney Corp PROK with a Equal-Weight rating. The price target for ProKidney is set to $13.00. In the second quarter, ProKidney showed an EPS of $0.12, compared to $0.09 from the year-ago quarter. The current stock performance of ProKidney shows a 52-week-high of $11.98 and a 52-week-low of $6.19. Moreover, at the end of the last trading period, the closing price was at $10.55.
For SunPower Corp SPWR, Guggenheim initiated coverage, by setting the current rating at Neutral. For the third quarter, SunPower had an EPS of $0.13, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $28.42 and a 52-week-low of $12.78. SunPower closed at $19.15 at the end of the last trading period.
With a Neutral rating, Goldman Sachs initiated coverage on Tyler Technologies Inc TYL. The price target seems to have been set at $322.00 for Tyler Technologies. In the third quarter, Tyler Technologies showed an EPS of $2.06, compared to $2.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $538.96 and a 52-week-low of $281.11. Tyler Technologies closed at $292.02 at the end of the last trading period.
Stifel initiated coverage on ZeroFox Holdings Inc ZFOX with a Buy rating. The price target for ZeroFox Holdings is set to $6.00. The stock has a 52-week-high of $15.65 and a 52-week-low of $3.26. At the end of the last trading period, ZeroFox Holdings closed at $4.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.